The 5-year analysis of GKB Ophthalmics Ltd's performance infers:
GKB Ophthalmics Ltd earnings have grown by 0%, whereas share price has appreciated 3.5% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.